Background: The optimal treatment of elderly patients with early-stage non-small-cell lung cancer (NSCLC) remains elusive. Still, the introduction of video-assisted thoracic surgery (VATS) and stereotactic body radiotherapy (SBRT) may have led to more elderly receiving treatment and improved median overall survival (OS). Materials and methods: We analysed data from the Netherlands Cancer Registry of 2168 patients >= 65 years with clinical stage I NSCLC and distinguished two periods: 2004-2008 (A) and 2009-2013 (B). The analyses focussed on treatment patterns and median OS for patients receiving surgery, radiotherapy or neither surgery nor radiotherapy. Furthermore, we explored the influence of the application of VATS and SBRT. Results: The ...
Introduction: Patterns of treatment and survival are largely unknown for older patients with stage I...
Introduction: Patterns of treatment and survival are largely unknown for older patients with stage I...
INTRODUCTION: Patterns of treatment and survival are largely unknown for older patients with stage I...
Background: The optimal treatment of elderly patients with early-stage non-small-cell lung cancer (N...
Background: The optimal treatment of elderly patients with early-stage non-small-cell lung cancer (N...
Background: The optimal treatment of elderly patients with early-stage non-small-cell lung cancer (N...
Background: The optimal treatment of elderly patients with early-stage non-small-cell lung cancer (N...
Objectives: Insights regarding utilization and survival of surgery and radiotherapy (stereotactic bo...
BACKGROUND: The aim of this article is to assess the influence of comorbidities among elderly patien...
Comparative studies of the overall survival (OS) in elderly patients with nonsmall cell lung cancer ...
OBJECTIVES: Resection is the standard treatment for stage I non-small cell lung cancer (NSCLC) in op...
Abstract Objective Standard medical treatment for early non‐small cell lung cancer (NSCLC) is surger...
Abstract Background Old age is an important factor that could affect the treatment of early-stage lu...
Objectives: Insights regarding utilization and survival of surgery and radiotherapy (stereotactic bo...
Background:Limited resection and stereotactic body radiotherapy (SBRT) have emerged as treatment opt...
Introduction: Patterns of treatment and survival are largely unknown for older patients with stage I...
Introduction: Patterns of treatment and survival are largely unknown for older patients with stage I...
INTRODUCTION: Patterns of treatment and survival are largely unknown for older patients with stage I...
Background: The optimal treatment of elderly patients with early-stage non-small-cell lung cancer (N...
Background: The optimal treatment of elderly patients with early-stage non-small-cell lung cancer (N...
Background: The optimal treatment of elderly patients with early-stage non-small-cell lung cancer (N...
Background: The optimal treatment of elderly patients with early-stage non-small-cell lung cancer (N...
Objectives: Insights regarding utilization and survival of surgery and radiotherapy (stereotactic bo...
BACKGROUND: The aim of this article is to assess the influence of comorbidities among elderly patien...
Comparative studies of the overall survival (OS) in elderly patients with nonsmall cell lung cancer ...
OBJECTIVES: Resection is the standard treatment for stage I non-small cell lung cancer (NSCLC) in op...
Abstract Objective Standard medical treatment for early non‐small cell lung cancer (NSCLC) is surger...
Abstract Background Old age is an important factor that could affect the treatment of early-stage lu...
Objectives: Insights regarding utilization and survival of surgery and radiotherapy (stereotactic bo...
Background:Limited resection and stereotactic body radiotherapy (SBRT) have emerged as treatment opt...
Introduction: Patterns of treatment and survival are largely unknown for older patients with stage I...
Introduction: Patterns of treatment and survival are largely unknown for older patients with stage I...
INTRODUCTION: Patterns of treatment and survival are largely unknown for older patients with stage I...